Imatinib plasma concentration and sokal risk score are independently prognostic for complete cytogenetic response (CCyR) in patients with chronic phase chronic myeloid leukemia (CML-CP)

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Larson RA, Druker BJ, Guilhot F, O'Brien SG, Krahnke T, Gathmann I, Wang YF

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Blood: 49th Annual Meeting of the American Society of Hematology

Year of Conference: 2007

Pages: 574A-575A no. 1935

ISSN: 0006-4971

Publisher: American Society of Hematology

URL: http://abstracts.hematologylibrary.org/cgi/content/abstract/110/11/1935

Library holdings: Search Newcastle University Library for this item

ISBN: 15280020

ePrints